Table 1 Demographic and characteristics of patients according to 6-month outcome
GOS 1–3 | GOS 4–5 | p | |
|---|---|---|---|
n = 19 | n = 29 | ||
Age, years | 55 ± 12 | 50 ± 10 | 0.14 |
Gender | |||
Women | 11 | 19 | 0.6 |
Men | 8 | 10 | |
SAPS II ± IQR | 34 ± 30 | 20 ± 13 | <0.01 |
GCS ± IQR | 14 ± 6 | 14 ± 2 | 0.01 |
Initial WFNS score, n (%) | 0.02 | ||
1–2 | 6 (32) | 22 (75) | |
3–5 | 13 (68) | 7 (25) | |
Initial Fisher score, n (%) | 0.8 | ||
1–2 | 2 (11) | 4 (14) | |
3–5 | 17 (89) | 25 (86) | |
Aneurism location, n (%) | 0.1 | ||
ACA + AComA | 13 (68) | 17 (58) | |
CA + PComA | 1 (5) | 8 (28) | |
MCA | 2 (11) | 4 (14) | |
Vertebrobasilar system | 3 (16) | 0 | |
Intraventricular hemorrhage, n (%) | 15 (79) | 17 (60) | 0.2 |
Intraparenchymentous hematoma, n (%) | 8 (42) | 6 (20) | 0.1 |
Hydrocephalus, n (%) | 15 (79) | 17 (60) | 0.2 |
Initial neurogenic lung edema, n (%) | 1 (5) | 3 (10) | 0.4 |
Delayed cerebral ischemia, n (%) | 13 (68) | 3 (11) | <0.001 |
Length of stay in ICU Median (range) | 37 (8–136) | 15(3–68) | 0.1 |
Hospital mortality, n (%) | 9 (47) | 0 | <0.001 |